Skip to main content
Alkem Laboratories Limited logo

Alkem Laboratories Limited — Investor Relations & Filings

Ticker · ALKEM ISIN · INE540L01014 LEI · 335800GCAE5WIF4PSG69 BSE.NS Manufacturing
Open in API
Filings indexed 1,788 across all filing types
Latest filing 2026-04-07 Regulatory Filings
Country IN India
Listing BSE.NS ALKEM

About Alkem Laboratories Limited

https://www.alkemlabs.com/

Alkem Laboratories Limited specializes in the development, manufacturing, and marketing of pharmaceutical and nutraceutical products. The company’s portfolio covers a wide range of therapeutic areas, including anti-infectives, gastrointestinal, pain management, and vitamins, minerals, and nutrients. It has also expanded into chronic therapeutic segments such as cardiology, diabetology, neurology, and dermatology. Alkem operates multiple manufacturing facilities and advanced research and development centers dedicated to formulation development and active pharmaceutical ingredients. The company provides branded generics, generic medications, and active pharmaceutical ingredients to various international markets. Its operations are supported by a robust supply chain and a focus on high-quality production standards to meet global regulatory requirements.

Recent filings

Filing Released Lang Actions
Please find attached herewith Press release- Alkem Launches A to Z Daily, an everyday multivitamin supplement for body and mind.
Regulatory Filings
2026-04-07 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing the launch of a new product, A to Z Daily, by Alkem Laboratories Limited. It is addressed to stock exchanges and includes a description of the product, its benefits, and a statement from the CEO. There is no financial data, regulatory filing, or report content. The document is informational and promotional in nature, typical of a press release. It does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. The best fitting category is Regulatory Filings (RNS) as a general announcement to the stock exchanges that does not fall into other specific categories.
2026-04-07 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings Classification · 75% confidence The document is a formal declaration under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, filed with the stock exchanges. It does not announce financial results, management changes, a proxy solicitation, or an actual report, nor does it fit any specific category like share issue or capital change. It is a regulatory disclosure to exchanges regarding promoter encumbrance. Therefore, it falls into the general Regulatory Filings (RNS) category.
2026-04-07 English
Please find attached herewith intimation about increase in investment to be made for setting up of manufacturing facility of the Company in Ujjain, Madhya Pradesh.
Regulatory Filings
2026-04-02 English
General Updates
Capital/Financing Update Classification · 95% confidence The document is a disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to continuous disclosure obligations for listed companies. It announces an increase in investment for setting up a manufacturing facility, which is a capital expenditure update. The document is short (1787 characters) and is an announcement of a change in investment plans, not a full financial report or detailed presentation. It does not contain financial statements or detailed analysis but rather an update on capital investment plans. Therefore, it fits best under Capital/Financing Update (CAP).
2026-04-02 English
Please find attached herewith Intimation regarding change in Senior Management.
Regulatory Filings
2026-03-31 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.